Related Experiment Videos

Diagnostic criteria for vascular dementia

P Scheltens1, A H Hijdra

  • 1Department of Neurology, Academisch Ziekenhuis VU, Amsterdam, The Netherlands. p.scheltens@azvu.nl

Haemostasis
|July 27, 1999
PubMed

Insights

Evaluating diagnostic criteria for vascular dementia (VaD), this review identifies the California and NINDS-AIREN criteria as most effective. Further research is needed to improve reliability, especially for differentiating mixed dementia types.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Vascular dementia (VaD) is a clinical syndrome of dementia linked to cerebrovascular disease.
  • Accurate diagnosis is crucial but challenging due to heterogeneous causes and overlapping pathologies.
  • Existing diagnostic criteria vary in their ability to define dementia, vascular disease, and their relationship.

Purpose of the Study:

  • To review and evaluate current diagnostic criteria for vascular dementia.
  • To assess the adequacy of these criteria in defining dementia, vascular pathology, and their causal link.
  • To identify the most reliable criteria for clinical and research use.

Main Methods:

  • Systematic review of established diagnostic criteria for vascular dementia.
  • Analysis of criteria based on their inclusion of diagnostic elements for dementia, cerebrovascular disease, and the relationship between them.
  • Evaluation of criteria's operational definitions and recommendations for neuroimaging (CT/MRI).

Main Results:

  • The criteria from the State of California Alzheimer's Disease Diagnostic and Treatment Centers and NINDS-AIREN were found to be the most comprehensive.
  • These selected criteria offer sufficient operational definitions for dementia in vascular disease patients.
  • They also provide a framework for diagnosing cerebrovascular disease and establishing its link to dementia.

Conclusions:

  • The California and NINDS-AIREN criteria are recommended for diagnosing vascular dementia.
  • Further investigation is required for interpreting neuroimaging in mixed vascular and degenerative dementia.
  • Improved diagnostic reliability for VaD is anticipated with the development of specific tests for differentiating degenerative diseases.

Related Concept Videos